Neuropsychological performance in early and late onset Alzheimer's disease: comparisons in a memory clinic population

2004 ◽  
Vol 19 (12) ◽  
pp. 1140-1147 ◽  
Author(s):  
Srinivas Suribhatla ◽  
Sarah Baillon ◽  
Michael Dennis ◽  
Mangesh Marudkar ◽  
Saquib Muhammad ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Late Onset ◽  
Neuropsychological Performance ◽  
Memory Clinic ◽  
Clinic Population

Neuropsychological performance in Alzheimer's disease and vascular dementia: comparisons in a memory clinic population

2003 ◽  
Vol 18 (7) ◽  
pp. 602-608 ◽  
Author(s):  
Sarah Baillon ◽  
Saquib Muhommad ◽  
Mangesh Marudkar ◽  
Srinivas Suribhatla ◽  
Michael Dennis ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Vascular Dementia ◽  
Neuropsychological Performance ◽  
Memory Clinic ◽  
Clinic Population

P1-371: New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population

2008 ◽  
Vol 4 ◽  
pp. T327-T328 ◽  
Author(s):  
Femke H. Bouwman ◽  
Nicolaas A. Verwey ◽  
Martin Klein ◽  
Yolande A.L. Pijnenburg ◽  
Astrid Kok ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Memory Clinic ◽  
New Research ◽  
Research Criteria ◽  
Clinic Population

scholarly journals Cerebrospinal fluid and saliva lactoferrin as a diagnostic biomarker for Alzheimer’s disease in a mixed memory clinic population

2021 ◽  
Vol 17 (S5) ◽  
Author(s):  
Helena Sophia Gleerup ◽  
Camilla Steen Jensen ◽  
Peter Høgh ◽  
Steen Gregers Hasselbalch ◽  
Anja Hviid Simonsen
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cerebrospinal Fluid ◽  
Diagnostic Biomarker ◽  
Memory Clinic ◽  
Clinic Population

scholarly journals Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: Validation in a large memory clinic population

2017 ◽  
Vol 27 (8) ◽  
pp. 3147-3155 ◽  
Author(s):  
Jules J. Claus ◽  
Salka S. Staekenborg ◽  
Dana C. Holl ◽  
Jelmen J. Roorda ◽  
Jacqueline Schuur ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Temporal Lobe ◽  
Medial Temporal Lobe ◽  
Memory Clinic ◽  
Medial Temporal Lobe Atrophy ◽  
Large Memory ◽  
Clinic Population ◽  
Lobe Atrophy

New Research Criteria for the Diagnosis of Alzheimer’s Disease Applied in a Memory Clinic Population

2010 ◽  
Vol 30 (1) ◽  
pp. 1-7 ◽  
Author(s):  
F.H. Bouwman ◽  
N.A. Verwey ◽  
M. Klein ◽  
A. Kok ◽  
M.A. Blankenstein ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Memory Clinic ◽  
New Research ◽  
Research Criteria ◽  
Clinic Population

Latent Cognitive Profiles Differ Between Incipient Alzheimer’s Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population

2020 ◽  
Vol 73 (3) ◽  
pp. 955-966
Author(s):  
Mattias Göthlin ◽  
Marie Eckerström ◽  
Magnus Lindwall ◽  
Sindre Rolstad ◽  
Carl Eckerström ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Vascular Lesions ◽  
Cognitive Profiles ◽  
Memory Clinic ◽  
Clinic Population

scholarly journals Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population

EBioMedicine ◽  
2021 ◽  
Vol 67 ◽  
pp. 103361
Author(s):  
Helena Sophia Gleerup ◽  
Camilla Steen Jensen ◽  
Peter Høgh ◽  
Steen Gregers Hasselbalch ◽  
Anja Hviid Simonsen
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cerebrospinal Fluid ◽  
Diagnostic Biomarker ◽  
Memory Clinic ◽  
Clinic Population

Familial Patterns of Risk in Very Late-Onset Alzheimer's Disease

2003 ◽  
Author(s):  
J. M. Silverman ◽  
C. J. Smith ◽  
D. B. Marin ◽  
R. C. Mohs ◽  
C. B. Propper
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Late Onset ◽  
Familial Patterns

Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer’s Disease

2020 ◽  
Vol 21 (12) ◽  
pp. 1164-1173
Author(s):  
Siju Ellickal Narayanan ◽  
Nikhila Sekhar ◽  
Rajalakshmi Ganesan Rajamma ◽  
Akash Marathakam ◽  
Abdullah Al Mamun ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Amyloid Precursor Protein ◽  
Early Onset ◽  
Late Onset ◽  
Precursor Protein ◽  
Brain Disorder ◽  
Amyloid Aβ ◽  
T Tau

: Alzheimer’s disease (AD) is a progressive brain disorder and one of the most common causes of dementia and death. AD can be of two types; early-onset and late-onset, where late-onset AD occurs sporadically while early-onset AD results from a mutation in any of the three genes that include amyloid precursor protein (APP), presenilin 1 (PSEN 1) and presenilin 2 (PSEN 2). Biologically, AD is defined by the presence of the distinct neuropathological profile that consists of the extracellular β-amyloid (Aβ) deposition in the form of diffuse neuritic plaques, intraneuronal neurofibrillary tangles (NFTs) and neuropil threads; in dystrophic neuritis, consisting of aggregated hyperphosphorylated tau protein. Elevated levels of (Aβ), total tau (t-tau) and phosphorylated tau (ptau) in cerebrospinal fluid (CSF) have become an important biomarker for the identification of this neurodegenerative disease. The aggregation of Aβ peptide derived from amyloid precursor protein initiates a series of events that involve inflammation, tau hyperphosphorylation and its deposition, in addition to synaptic dysfunction and neurodegeneration, ultimately resulting in dementia. The current review focuses on the role of proteomes in the pathogenesis of AD.

Sign in / Sign up

Export Citation Format

Share Document